Restricted substances: evidencing what is inside a product you did not wholly make

The restriction follows the material into whatever it becomes

Restrictions of this kind are written against substances and their concentration in defined portions of an article, not against product categories, so they surface in places the design team never considered. The pigment in a moulded part, the residue on a plated component, the adhesive in a laminate and the ink on a printed label are all candidates. Because the concentration is often assessed against a homogeneous portion rather than the whole product, a small component with a high concentration can be the problem even where the assembly as a whole would look unremarkable. That framing is what makes intuition unreliable here.

The evidence problem is really a sub-tier visibility problem

Your supplier knows what they bought, not necessarily what their supplier's supplier used. Declarations therefore weaken as they travel down the tiers, and a confident statement at the top can rest on nothing at the bottom. Businesses that manage this well pick a small number of high-risk materials and pursue them properly, asking for full material disclosure rather than a yes-or-no assertion, understanding which components change source frequently, and recognising that a distributor selling from stock may hold parts from several original makers under one part number.

The lists are living documents, and additions are retrospective in effect

Substances get added as evidence about them accumulates, and a design frozen years ago can drift out of compliance without anything about the product changing. Some regimes also impose duties to communicate, or to notify authorities, when a listed substance is present in an article above a stated concentration, which turns list changes into an operational trigger rather than a background concern. Somebody therefore has to watch for updates, translate them into a question for the bill of materials, and record the outcome, because the absence of that routine is what makes an addition arrive as a customer complaint.

Testing answers a narrow question with useful precision

Analytical testing tells you about the sample submitted, prepared in a particular way, for the substances requested. It cannot tell you about a different production lot, a component the supplier substituted last month, or a substance nobody thought to include in the scope. Screening methods can indicate the presence of an element without identifying which compound it belongs to, which matters when only some compounds are restricted. Used well, testing verifies declarations on a risk basis and catches suppliers whose paperwork is better than their material control. Used as the whole programme, it is expensive and still incomplete.

Contract terms are the only control that lasts

Durable arrangements put the requirement into purchasing documents rather than into an annual email campaign: a stated obligation to meet named restrictions, a duty to notify before changing materials or sources, a right to request full disclosure, a right to test, and consequences that make notification cheaper than silence. Restrictions, concentration thresholds, notification duties and listed substances differ between jurisdictions and are revised regularly, so treat this description as orientation rather than legal advice and work from the publications of the relevant chemicals or environmental agency.

Frequently asked questions

Is a signed supplier declaration sufficient evidence?

It is necessary and rarely sufficient. A declaration records what the supplier asserts, which may rest on their own supplier's assertion and so on down the chain. Its value depends on whether the supplier understands the question, controls its own sources and would know if something changed. Risk-based verification through material disclosure or testing on the components most likely to carry restricted substances is what converts a pile of declarations into evidence that would withstand a challenge.

A substance was added to a restricted list after our product was designed. What happens now?

Additions typically apply to what is placed on the market from the point they take effect rather than to units already sold, but transitional arrangements vary and some regimes treat existing stock differently from new production. The practical work is the same in each case: determine whether the substance is present, in which components, at what concentration, then decide between reformulating, resourcing or seeking whatever route the legislation provides. Establish the timing question with the regulator early, because it drives everything else.

Do restrictions reach components we import for our own assembly?

Generally yes, and importing tends to concentrate responsibility rather than dilute it, since the party bringing goods into a market often carries duties the overseas maker does not. A component that was entirely lawful where it was produced can be restricted where you sell the finished product. Building the requirement into purchase specifications and incoming checks for imported parts is more effective than discovering the issue when a customer runs their own testing programme.